LPCN
Lipocine Inc
NASDAQ: LPCN · HEALTHCARE · BIOTECHNOLOGY
$2.33
+0.00% today
Updated 2026-05-01
Market cap
$19.02M
P/E ratio
—
P/S ratio
9.62x
EPS (TTM)
$-1.77
Dividend yield
—
52W range
$2 – $12
Volume
0.5M
Lipocine Inc (LPCN) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |